High-risk human papillomaviruses (HPVs) cause essentially all cervical cancers, most anal
and oropharyngeal cancers, and some vaginal, vulvar, and penile cancers. Improved …

Human papillomaviruses (HPVs) are the etiological agents of several genital cancers,
including cancer of the uterine cervix. The detection of HPV infection in genital samples may …

Human papillomavirus (HPV) infection is associated with a wide spectrum of disease that
ranges from self-limited skin warts to life-threatening cancers. Since HPV plays a necessary …

Recent technologic advances indicate the potential role and applications of human
papillomavirus (HPV) DNA testing in the routine screening for cervical neoplasia, diagnostic …

Human papillomavirus (HPV) DNA testing was recently approved by the Food and Drug
Administration for use as an adjunct to cytology for cervical cancer screening. To help …

Testing for high-risk types of alpha human papillomaviruses (HPV) is an invaluable part of
clinical guidelines for cervical carcinoma screening, management and treatment. In this …

Background Testing for high-risk HPV is more effective in primary cervical cancer screening
than the cytological examination of a Pap smear. Separate genotyping may be useful for …

Much recent attention has highlighted a subset of head and neck squamous cell carcinomas
(HNSCCs) related to human papillomavirus (HPV) that has an epidemiologic, demographic …

Background Molecular tests for detection of human papillomaviruses (HPVs) play a crucial
role in the prevention of cervical cancer, including recently announced elimination efforts …

Of the many types of human papillomavirus (HPV), more than 30 infect the genital tract. The
association between certain oncogenic (high-risk) strains of HPV and cervical cancer is well …